ID: ALA4218178

Max Phase: Preclinical

Molecular Formula: C18H17N7OS

Molecular Weight: 379.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(N2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)c2ncsc2n1

Standard InChI:  InChI=1S/C18H17N7OS/c19-18-22-15(14-16(23-18)27-10-20-14)24-5-7-25(8-6-24)17(26)13-9-11-3-1-2-4-12(11)21-13/h1-4,9-10,21H,5-8H2,(H2,19,22,23)

Standard InChI Key:  WPPOSOGWMNQIDJ-UHFFFAOYSA-N

Associated Targets(Human)

PI4-kinase beta subunit 1593 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 379.45Molecular Weight (Monoisotopic): 379.1215AlogP: 2.11#Rotatable Bonds: 2
Polar Surface Area: 104.03Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.35CX LogP: 2.06CX LogD: 2.06
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -1.50

References

1. Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R..  (2018)  Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.,  61  (15): [PMID:29952567] [10.1021/acs.jmedchem.8b00521]

Source